Funder: National Institutes of Health (NIH)
Due Dates: November 21, 2024 | December 20, 2024 (AIDS)
Funding Amounts: Up to $300,000 direct costs per year | Project period up to 2 years
Summary: Supports advanced development and rigorous validation of novel enabling technologies and transformative platforms for heart, lung, blood, and sleep (HLBS) disorders, excluding clinical trials.
Key Information: Applications must demonstrate overcoming major feasibility gaps with preliminary data; clinical trials are not allowed; projects must focus on technology development, not biological or clinical hypotheses.